Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $253.55
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-four research firms that are covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 12-month price objective among […]
More Stories
Birchcreek Wealth Management LLC Makes New $213,000 Investment in U.S. Bancorp (NYSE:USB)
Birchcreek Wealth Management LLC bought a new position in U.S. Bancorp (NYSE:USB – Free Report) in the third quarter, according...
iShares Core S&P U.S. Growth ETF (NASDAQ:IUSG) Shares Sold by Birchcreek Wealth Management LLC
Birchcreek Wealth Management LLC lowered its stake in iShares Core S&P U.S. Growth ETF (NASDAQ:IUSG – Free Report) by 0.2%...
Archer Investment Corp Buys Shares of 69,397 BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF (NYSEARCA:XSVN)
Archer Investment Corp purchased a new stake in shares of BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF (NYSEARCA:XSVN...
Birchcreek Wealth Management LLC Purchases 25,627 Shares of Dimensional U.S. Small Cap ETF (NYSEARCA:DFAS)
Birchcreek Wealth Management LLC boosted its position in shares of Dimensional U.S. Small Cap ETF (NYSEARCA:DFAS – Free Report) by...
Birchcreek Wealth Management LLC Lowers Holdings in Vanguard Energy ETF (NYSEARCA:VDE)
Birchcreek Wealth Management LLC lowered its position in shares of Vanguard Energy ETF (NYSEARCA:VDE – Free Report) by 1.8% in...
Sonos Target of Unusually High Options Trading (NASDAQ:SONO)
Sonos, Inc. (NASDAQ:SONO – Get Free Report) was the target of unusually large options trading on Thursday. Stock traders bought...